Dr. White is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1161 21st Ave Mcn S
# D3100
Nashville, TN 37232Phone+1 615-343-0339Fax+1 615-936-0605
Summary
- Dr. Katie White is an infectious disease specialist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. She received her medical degree from University of Alabama School of Medicine and has been in practice 11 years.
Education & Training
Vanderbilt University Medical CenterFellowship, Infectious Disease, 2012 - 2013- Vanderbilt University Medical CenterResidency, Internal Medicine, 2010 - 2012
University of Alabama School of MedicineClass of 2010
Certifications & Licensure
TN State Medical License 2013 - 2026
AL State Medical License 2020 - 2020- American Board of Internal Medicine Infectious Disease
- American Board of Preventive Medicine Addiction Medicine
Publications & Presentations
PubMed
- 3 citationsGram stain to the rescue: a case report of cerebral phaeohyphomycosis by Cladophialophora bantiana in an immunocompetent 24-year-old.Perceus Mody, Paul Wada, Karen C Bloch, Michail S Lionakis, Katie D White
BMC Infectious Diseases. 2022-01-04 - 32 citationsApplications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions.Jason H. Karnes, Matthew A. Miller, Katie D. White, Katherine C. Konvinse, Rebecca Pavlos
Annual Review of Pharmacology and Toxicology. 2019-01-06 - 65 citationsHLAs: Key regulators of T‐cell‐mediated drug hypersensitivityAlec J. Redwood, Rebecca Pavlos, Katie D. White, Elizabeth J. Phillips
HLA. 2018-01-01
Press Mentions
Case Tally up by 49; Deaths Increase by 3May 25th, 2021- RewiredApril 26th, 2021
Salbutamol Use in Relation to Maintenance Bronchodilator Efficacy in COPD: A Prospective Subgroup Analysis of the EMAX TrialOctober 22nd, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
